Skip to main content
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Ziyou Lin
Sign up to set email alerts
42
Publications
1,477
Citation Statements Received
1,197
Citation Statements Given
How they've been cited
2,454
47
1,426
4
How they cite others
1,386
50
1,147
0
Affiliations
Sun Yat-sen University
,
Tongji University
Publications
Order By: Most citations
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
Niu
1
,
Lin
2
,
Wan
3
et al.
2019
Mol Cancer
Abstract
Show
641
24
509
4
Get access via publisher
Add to collection
Cite
RNA m6A methylation regulates sorafenib resistance in liver cancer through FOXO3‐mediated autophagy
Lin
1
,
Niu
2
,
Wan
3
et al.
2020
EMBO J
Abstract
Show
488
7
263
0
Get access via publisher
Add to collection
Cite
Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer
Ouyang
1
,
Li
2
,
Lou
3
et al.
2022
Redox Biology
515
7
236
0
Get access via publisher
Add to collection
Cite
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer
Sun
1
,
Wan
2
,
Zhou
3
et al.
2020
Gut
Abstract
Show
135
2
79
0
1
Get access via publisher
Add to collection
Cite
Loss‐of‐Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia
Niu
1
,
Lin
2
,
Wan
3
et al.
2021
Hepatology
Abstract
Show
143
2
75
0
Get access via publisher
Add to collection
Cite
N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development
Niu
1
,
Wan
2
,
Lin
3
et al.
2018
Acta Pharmaceutica Sinica B
Abstract
Show
106
0
73
0
Get access via publisher
Add to collection
Cite
N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis
Lin
1
,
Wan
2
,
Sun
3
et al.
2023
Molecular Therapy
84
2
49
0
Get access via publisher
Add to collection
Cite
Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer
Lin
1
,
Li
2
,
Zhang
3
et al.
2023
Abstract
Show
153
1
50
0
Get access via publisher
Add to collection
Cite
1
2
3
4
5
